Capulzini Lucio, Vergara Pasquale, Mugnai Giacomo, Salghetti Francesca, Abugattas Juan Pablo, El Bouchaibi Said, Iacopino Saverio, Sieira Juan, Enriquez Coutiño Hugo, Ströker Erwin, Brugada Pedro, Chierchia Gianbattista, de Asmundis Carlo
Heart Rhythm Management Centre Universitair Ziekenhuis Brussel Postgraduate Program in Cardiac Electrophysiology and Pacing Vrije Universiteit Brussel Brussels Belgium.
Division of Radiology EpiCURA Hospital Hornu Belgium.
J Arrhythm. 2019 May 14;35(3):542-549. doi: 10.1002/joa3.12194. eCollection 2019 Jun.
Radiofrequency (RF) ablation is a well-established approach to treat premature ventricular contractions (PVC) and is associated with good outcomes.
The present study sought to analyze the acute efficacy and 1-year outcomes of PVC ablation using RF technology with an approach based on automated pace-mapping and contact force (CF) information.
Sixty-one consecutive patients (52.4% males, age 45.9 ± 12.5) underwent catheter ablation for symptomatic monomorphic PVC. All procedures were guided by a 3-dimensional mapping system; site of ablation was selected based on PASO aided pace-mapping; RF was started on the selected location when stable catheter position with >10 g of CF were obtained.The procedure was defined as acutely effective if the PVC was eliminated and it did not recur during within 30 minutes. Long-term efficacy was defined as a decrease by more than 95% at 1 year of the initial PVC burden at ECG Holter monitoring.
The PVC ablation was performed in the right ventricular outflow tract in 37 patients (60.7%), left ventricle in 15 patients (24.6%), coronary cusps in 6 patients (9.8%), right ventricle in 3 patients (4.9%); PVC ablation was acutely successful in 59 of patients (96.7%). At 1-year efficacy was obtained in 57 patients (93.4%). No major complications occurred. Mean procedural and fluoroscopy time were 94.5 ± 20.9 and 4.3 ± 2.5 minutes respectively.
Premature ventricular contraction RF ablation mainly guided by PASO and CF showed high success rate in both acute and 1-year follow-up (96.7% and 93.4% respectively). The best efficacy cut-off for RF ablation of PVCs has been identified in presence of both PASO ≥95% and CF >10 g.
射频(RF)消融是一种成熟的治疗室性早搏(PVC)的方法,且疗效良好。
本研究旨在分析基于自动起搏标测和接触力(CF)信息的射频技术用于PVC消融的急性疗效和1年结局。
61例连续性患者(男性占52.4%,年龄45.9±12.5岁)因症状性单形性PVC接受导管消融。所有手术均在三维标测系统引导下进行;根据PASO辅助起搏标测选择消融部位;当导管位置稳定且CF>10g时,在选定部位开始射频消融。若PVC在30分钟内消除且未复发,则该手术定义为急性有效。长期疗效定义为在心电图动态监测1年时,初始PVC负荷降低超过95%。
37例患者(60.7%)在右心室流出道进行PVC消融,15例患者(24.6%)在左心室,6例患者(9.8%)在冠状窦,3例患者(4.9%)在右心室;59例患者(96.7%)PVC消融急性成功。1年时57例患者(93.4%)获得疗效。未发生重大并发症。平均手术时间和透视时间分别为94.5±20.9分钟和4.3±2.5分钟。
以PASO和CF为主导的室性早搏射频消融在急性和1年随访中均显示出高成功率(分别为96.7%和93.4%)。在PASO≥95%且CF>10g的情况下,已确定了PVC射频消融的最佳疗效阈值。